Stay updated with breaking news from Registration Document. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ordinary general meeting of shareholders, 24th May 2024 Arrangements for making preparatory documents available and consulting them Paris, 23 April 2024 The Ordinary General Meeting of shareholders...
“After closing 2023 with over €270 million Revenues and reaching the EBITDA target, first quarter 2024 started with double-digit growth across all business units and revenues up +57% year-on-year...
PRESS RELEASE Q1 2024 Trading and Operational update After closing 2023 with over €270 million Revenues and...
April 19, 2024 Dear Shareholders, We are preparing to gather again at the Teleperformance 2024 AGM on May 23rd to discuss the progress made...
Press Release GenSight Biologics Announces the Filing of its 2023 Universal Registration Document Paris, France, April...